Red Light Holland Engages Kala Bio's Researgency.ai Platform to Support Clinical Development of Filament Health's Patented PEX010 Botanical Psilocybin Drug Candidate
Go back to Red Light Holland Engages Kala Bio's Researgency.ai Platform to Support Clinical Development of Filament Health's Patented PEX010 Botanical Psilocybin Drug Candidate| (NASDAQ: KALA) | Delayed: 1.09 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.09 | 52 Week High | $ | |||
| Open | $1.09 | 52 Week Low | $ | |||
| Day High | $1.09 | P/E | N/A | |||
| Day Low | $1.09 | EPS | $ | |||
| Volume | 4,875 | |||||
| (AMEX: TRUFF) | Delayed: 0.02 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.02 | 52 Week High | $ | |||
| Open | $0.02 | 52 Week Low | $ | |||
| Day High | $0.02 | P/E | N/A | |||
| Day Low | $0.02 | EPS | $ | |||
| Volume | 18,072 | |||||
